BeOne Medicines
ONC
#636
Rank
โ‚น3.483 T
Marketcap
โ‚น31,483
Share price
1.36%
Change (1 day)
62.84%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: โ‚น3.483 Trillion

As of February 2026 BeOne Medicines has a market cap of โ‚น3.483 Trillion. This makes BeOne Medicines the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น3.483 T12.27%
2025โ‚น3.103 T76.63%
2024โ‚น1.756 T7.06%
2023โ‚น1.641 T-22.02%
2022โ‚น2.104 T1.74%
2021โ‚น2.068 T19.5%
2020โ‚น1.731 T137.57%
2019โ‚น728.63 B24.68%
2018โ‚น584.38 B105.65%
2017โ‚น284.17 B247.13%
2016โ‚น81.86 B

End of Day market cap according to different sources

On Feb 2nd, 2026 the market cap of BeOne Medicines was reported to be:

โ‚น3.483 Trillion
by Nasdaq info icon info icon
โ‚น3.483 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
OPKO Health
OPK
โ‚น92.71 B-97.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น1.90 B-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA